Wang Xiao Fang
Wang Xiao Fang — Chief Physician — Hematology — Tianjin Medical University Cancer Hospital
Specialties
Specializes in various malignant hematologic tumors, including malignant lymphoma, multiple myeloma, acute and chronic leukemia, as well as the diagnosis and treatment of anemia and thrombocytopenia.
Education
In June 2005, graduated from Fudan University with a PhD in Internal Medicine (Hematology).
Professional Experience
He/She has led the completion of two National Natural Science Foundation projects, "Study on the Role of Mesenchymal Stem Cells in Drug Resistance of Multiple Myeloma" and "Study on the Role of Mesenchymal Stem Cells in Angiogenesis of Multiple Myeloma," one of which has been registered as a municipal science and technology achievement; participated in the completion of one National Natural Science Foundation project (second principal contributor), and the municipal science and technology achievement has been registered. As the first author, he/she has published more than twenty articles in domestic and international core journals, including more than ten SCI articles. The "Study on Prognosis Judgment and Treatment Strategies of B-Cell Tumors with the Same Differentiation Degree" won the second prize of the China Anti-Cancer Association in 2016 (4th contributor).
Professional Roles
Standing Member of the Hematologic Disease Prevention and Treatment Committee of the Tianjin Anti-Aging Society Member of the Hematology Physicians Branch of the Tianjin Medical Association Member of the Hematology Oncology Committee of the Chinese Anti-Cancer Association Member of the Lymphoma Committee of the Chinese Anti-Cancer Association Youth Member of the Tianjin Society of Integrated Traditional Chinese and Western Medicine